Drug Repurposing for Rare Diseases

Helen, I Roessler, Nine V. A. M. Knoers, Mieke M. van Haelst, Gijs van Haaften

Research output: Contribution to journalReview articleAcademicpeer-review

93 Citations (Scopus)

Abstract

Currently, there are about 7000 identified rare diseases, together affecting 10% of the population. However, fewer than 6% of all rare diseases have an approved treatment option, highlighting their tremendous unmet needs in drug development. The process of repurposing drugs for new indications, compared with the development of novel orphan drugs, is a time-saving and cost-efficient method resulting in higher success rates, which can therefore drastically reduce the risk of drug development for rare diseases. Although drug repurposing is not novel, new strategies have been developed in recent years to do it in a systematic and rational way. Here, we review applied methodologies, recent accomplished progress, and the challenges associated in drug repurposing for rare diseases.
Original languageEnglish
Pages (from-to)255-267
Number of pages13
JournalTrends in pharmacological sciences
Volume42
Issue number4
Early online date2021
DOIs
Publication statusPublished - Apr 2021

Keywords

  • drug discovery
  • drug repositioning
  • drug repurposing
  • genetic diseases
  • rare diseases

Cite this